Nutrition, Muscle and Strength: Paramount for Optimal Health
Publication Date: 6 April 2023
Continuing Education Units: Nurse Contact: 1.0; Dietitian CPEU: 1.0
Course Description:
In this course, Alfonso J. Cruz-Jentoft, MD, PhD and Philip J Atherton, PhD, AFHEA will explain the new pandemic of sarcopenia and frailty after COVID-19 in the older adult population; review the impact of long-COVID on muscle and nutritional outcomes; summarize the new GLIM body composition guidelines; and more!Course Objectives:
• Explain the new pandemic of sarcopenia and frailty after COVID-19 in the older adult population.
• Review the impact of long COVID on muscle and nutritional outcomes in older adults.
• Summarize the new GLIM body composition guidelines.
• Review new data and expert consensus on protein intake for muscle health.
• Summarize new evidence on β-Hydroxy-β-Methylbutyrate (HMB) on muscle outcomes.
- CDR Level: 2
- Performance Indicators: 4.2.1, 4.2.5, 10.2.5
- Run Time: 37
Course Instructor Bio(s)

Alfonso J. Cruz-Jentoft, MD, PhD
Jefe del Servicio de Geriatría
Hospital Universitario Ramón y Cajal
Madrid, Spain
Prof. Alfonso J. Cruz-Jentoft, MD, PhD is a specialist in Geriatric Medicine, Chair of the Geriatric Department at the Hospital Universitario Ramón y Cajal in Madrid, Spain, Professor of Geriatrics at the Universidad Europea de Madrid and Chair of the Spanish National Board of Geriatrics. He is a corresponding member of the Real Academia Nacional de Medicina de España and Past President of the European Geriatric Medicine Society (EuGMS). Dr Cruz-Jentof serves as the Editor-in-Chief of European Geriatric Medicine, the official journal of the EuGMS. Chair of the European Working Group on Sarcopenia in Older People (EWGSOP) and is a member of the WHO Clinical Consortium on Healthy Ageing. He represents Spain on the Board of the International Association of Gerontology and Geriatrics (IAGG). In addition, he serves on the editorial boards of most major geriatric medicine journals.

Philip J Atherton, PhD, AFHEA
Chair of Clinical, Metabolic, & Molecular Physiology School of Medicine
Faculty of Medicine and Health Sciences
University of Nottingham
Derby, Derbyshire, UK
Dr Philip J. Atherton is Chair of Clinical, Metabolic, and Molecular Physiology at the University of Nottingham in the United Kingdom. He received a 1st Class BSc degree, and a higher PhD degree (in 2005) focusing upon protein metabolism, myogenic signaling, and gene expression regulation in skeletal muscle, from the University of Central Lancashire. His current research involves an expansive combining of detailed pre/clinical molecular physiology with the application of stable isotope methodologies and the integration of OMIC techniques to discover predictors of the mechanistic basis for, and how to mitigate musculoskeletal declines in aging and myriad related diseases. Atherton, with a H-index of 57 and ~15000 citations, has published ~150 peer-reviewed articles and 6 invited book chapters. He is a senior editor for Experimental Physiology, Applied Physiology, Nutrition & Metabolism, and Nutrients, journals.

attended a live program?
FREQUENTLY ASKED QUESTIONS
continuing medical education courses